1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Fulvestrant Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Fulvestrant Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Fulvestrant Injection by Country/Region, 2018, 2022 & 2029
2.2 Fulvestrant Injection Segment by Type
2.2.1 Original Drugs
2.2.2 Generic Drugs
2.3 Fulvestrant Injection Sales by Type
2.3.1 Global Fulvestrant Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Fulvestrant Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Fulvestrant Injection Sale Price by Type (2018-2023)
2.4 Fulvestrant Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Fulvestrant Injection Sales by Application
2.5.1 Global Fulvestrant Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Fulvestrant Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Fulvestrant Injection Sale Price by Application (2018-2023)
3 Global Fulvestrant Injection by Company
3.1 Global Fulvestrant Injection Breakdown Data by Company
3.1.1 Global Fulvestrant Injection Annual Sales by Company (2018-2023)
3.1.2 Global Fulvestrant Injection Sales Market Share by Company (2018-2023)
3.2 Global Fulvestrant Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Fulvestrant Injection Revenue by Company (2018-2023)
3.2.2 Global Fulvestrant Injection Revenue Market Share by Company (2018-2023)
3.3 Global Fulvestrant Injection Sale Price by Company
3.4 Key Manufacturers Fulvestrant Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fulvestrant Injection Product Location Distribution
3.4.2 Players Fulvestrant Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Fulvestrant Injection by Geographic Region
4.1 World Historic Fulvestrant Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Fulvestrant Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Fulvestrant Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Fulvestrant Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Fulvestrant Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Fulvestrant Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Fulvestrant Injection Sales Growth
4.4 APAC Fulvestrant Injection Sales Growth
4.5 Europe Fulvestrant Injection Sales Growth
4.6 Middle East & Africa Fulvestrant Injection Sales Growth
5 Americas
5.1 Americas Fulvestrant Injection Sales by Country
5.1.1 Americas Fulvestrant Injection Sales by Country (2018-2023)
5.1.2 Americas Fulvestrant Injection Revenue by Country (2018-2023)
5.2 Americas Fulvestrant Injection Sales by Type
5.3 Americas Fulvestrant Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fulvestrant Injection Sales by Region
6.1.1 APAC Fulvestrant Injection Sales by Region (2018-2023)
6.1.2 APAC Fulvestrant Injection Revenue by Region (2018-2023)
6.2 APAC Fulvestrant Injection Sales by Type
6.3 APAC Fulvestrant Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Fulvestrant Injection by Country
7.1.1 Europe Fulvestrant Injection Sales by Country (2018-2023)
7.1.2 Europe Fulvestrant Injection Revenue by Country (2018-2023)
7.2 Europe Fulvestrant Injection Sales by Type
7.3 Europe Fulvestrant Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Fulvestrant Injection by Country
8.1.1 Middle East & Africa Fulvestrant Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Fulvestrant Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Fulvestrant Injection Sales by Type
8.3 Middle East & Africa Fulvestrant Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fulvestrant Injection
10.3 Manufacturing Process Analysis of Fulvestrant Injection
10.4 Industry Chain Structure of Fulvestrant Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fulvestrant Injection Distributors
11.3 Fulvestrant Injection Customer
12 World Forecast Review for Fulvestrant Injection by Geographic Region
12.1 Global Fulvestrant Injection Market Size Forecast by Region
12.1.1 Global Fulvestrant Injection Forecast by Region (2024-2029)
12.1.2 Global Fulvestrant Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Fulvestrant Injection Forecast by Type
12.7 Global Fulvestrant Injection Forecast by Application
13 Key Players Analysis
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Fulvestrant Injection Product Portfolios and Specifications
13.1.3 AstraZeneca Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Sichuan Huiyu Pharmaceutical Co., Ltd.
13.2.1 Sichuan Huiyu Pharmaceutical Co., Ltd. Company Information
13.2.2 Sichuan Huiyu Pharmaceutical Co., Ltd. Fulvestrant Injection Product Portfolios and Specifications
13.2.3 Sichuan Huiyu Pharmaceutical Co., Ltd. Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sichuan Huiyu Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Sichuan Huiyu Pharmaceutical Co., Ltd. Latest Developments
13.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
13.3.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
13.3.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Fulvestrant Injection Product Portfolios and Specifications
13.3.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Latest Developments
13.4 Lunan Pharmaceutical Group Corporation
13.4.1 Lunan Pharmaceutical Group Corporation Company Information
13.4.2 Lunan Pharmaceutical Group Corporation Fulvestrant Injection Product Portfolios and Specifications
13.4.3 Lunan Pharmaceutical Group Corporation Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lunan Pharmaceutical Group Corporation Main Business Overview
13.4.5 Lunan Pharmaceutical Group Corporation Latest Developments
13.5 Hansoh Pharmaceutical Group Company Limited
13.5.1 Hansoh Pharmaceutical Group Company Limited Company Information
13.5.2 Hansoh Pharmaceutical Group Company Limited Fulvestrant Injection Product Portfolios and Specifications
13.5.3 Hansoh Pharmaceutical Group Company Limited Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hansoh Pharmaceutical Group Company Limited Main Business Overview
13.5.5 Hansoh Pharmaceutical Group Company Limited Latest Developments
13.6 Qilu Pharmaceutical
13.6.1 Qilu Pharmaceutical Company Information
13.6.2 Qilu Pharmaceutical Fulvestrant Injection Product Portfolios and Specifications
13.6.3 Qilu Pharmaceutical Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Qilu Pharmaceutical Main Business Overview
13.6.5 Qilu Pharmaceutical Latest Developments
13.7 Vetter Pharma-Fertigung GmbH & Co. KG
13.7.1 Vetter Pharma-Fertigung GmbH & Co. KG Company Information
13.7.2 Vetter Pharma-Fertigung GmbH & Co. KG Fulvestrant Injection Product Portfolios and Specifications
13.7.3 Vetter Pharma-Fertigung GmbH & Co. KG Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Vetter Pharma-Fertigung GmbH & Co. KG Main Business Overview
13.7.5 Vetter Pharma-Fertigung GmbH & Co. KG Latest Developments
13.8 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
13.8.1 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Company Information
13.8.2 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Fulvestrant Injection Product Portfolios and Specifications
13.8.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Latest Developments
13.9 Sandoz
13.9.1 Sandoz Company Information
13.9.2 Sandoz Fulvestrant Injection Product Portfolios and Specifications
13.9.3 Sandoz Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sandoz Main Business Overview
13.9.5 Sandoz Latest Developments
13.10 Hikma Pharmaceuticals
13.10.1 Hikma Pharmaceuticals Company Information
13.10.2 Hikma Pharmaceuticals Fulvestrant Injection Product Portfolios and Specifications
13.10.3 Hikma Pharmaceuticals Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hikma Pharmaceuticals Main Business Overview
13.10.5 Hikma Pharmaceuticals Latest Developments
13.11 Teva Pharmaceuticals
13.11.1 Teva Pharmaceuticals Company Information
13.11.2 Teva Pharmaceuticals Fulvestrant Injection Product Portfolios and Specifications
13.11.3 Teva Pharmaceuticals Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Teva Pharmaceuticals Main Business Overview
13.11.5 Teva Pharmaceuticals Latest Developments
13.12 Eugia US
13.12.1 Eugia US Company Information
13.12.2 Eugia US Fulvestrant Injection Product Portfolios and Specifications
13.12.3 Eugia US Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Eugia US Main Business Overview
13.12.5 Eugia US Latest Developments
13.13 Xiromed LLC
13.13.1 Xiromed LLC Company Information
13.13.2 Xiromed LLC Fulvestrant Injection Product Portfolios and Specifications
13.13.3 Xiromed LLC Fulvestrant Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Xiromed LLC Main Business Overview
13.13.5 Xiromed LLC Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Fulvestrant Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Fulvestrant Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Original Drugs
Table 4. Major Players of Generic Drugs
Table 5. Global Fulvestrant Injection Sales by Type (2018-2023) & (K Units)
Table 6. Global Fulvestrant Injection Sales Market Share by Type (2018-2023)
Table 7. Global Fulvestrant Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Fulvestrant Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Fulvestrant Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Fulvestrant Injection Sales by Application (2018-2023) & (K Units)
Table 11. Global Fulvestrant Injection Sales Market Share by Application (2018-2023)
Table 12. Global Fulvestrant Injection Revenue by Application (2018-2023)
Table 13. Global Fulvestrant Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Fulvestrant Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Fulvestrant Injection Sales by Company (2018-2023) & (K Units)
Table 16. Global Fulvestrant Injection Sales Market Share by Company (2018-2023)
Table 17. Global Fulvestrant Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Fulvestrant Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Fulvestrant Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Fulvestrant Injection Producing Area Distribution and Sales Area
Table 21. Players Fulvestrant Injection Products Offered
Table 22. Fulvestrant Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Fulvestrant Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Fulvestrant Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Fulvestrant Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Fulvestrant Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Fulvestrant Injection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Fulvestrant Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Fulvestrant Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Fulvestrant Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Fulvestrant Injection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Fulvestrant Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Fulvestrant Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Fulvestrant Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Fulvestrant Injection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Fulvestrant Injection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Fulvestrant Injection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Fulvestrant Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Fulvestrant Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Fulvestrant Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Fulvestrant Injection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Fulvestrant Injection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Fulvestrant Injection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Fulvestrant Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Fulvestrant Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Fulvestrant Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Fulvestrant Injection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Fulvestrant Injection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Fulvestrant Injection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Fulvestrant Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Fulvestrant Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Fulvestrant Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Fulvestrant Injection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Fulvestrant Injection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Fulvestrant Injection
Table 58. Key Market Challenges & Risks of Fulvestrant Injection
Table 59. Key Industry Trends of Fulvestrant Injection
Table 60. Fulvestrant Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Fulvestrant Injection Distributors List
Table 63. Fulvestrant Injection Customer List
Table 64. Global Fulvestrant Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Fulvestrant Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Fulvestrant Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Fulvestrant Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Fulvestrant Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Fulvestrant Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Fulvestrant Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Fulvestrant Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Fulvestrant Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Fulvestrant Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Fulvestrant Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Fulvestrant Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Fulvestrant Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Fulvestrant Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. AstraZeneca Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. AstraZeneca Fulvestrant Injection Product Portfolios and Specifications
Table 80. AstraZeneca Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. AstraZeneca Main Business
Table 82. AstraZeneca Latest Developments
Table 83. Sichuan Huiyu Pharmaceutical Co., Ltd. Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Sichuan Huiyu Pharmaceutical Co., Ltd. Fulvestrant Injection Product Portfolios and Specifications
Table 85. Sichuan Huiyu Pharmaceutical Co., Ltd. Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Sichuan Huiyu Pharmaceutical Co., Ltd. Main Business
Table 87. Sichuan Huiyu Pharmaceutical Co., Ltd. Latest Developments
Table 88. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Fulvestrant Injection Product Portfolios and Specifications
Table 90. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Main Business
Table 92. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Latest Developments
Table 93. Lunan Pharmaceutical Group Corporation Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Lunan Pharmaceutical Group Corporation Fulvestrant Injection Product Portfolios and Specifications
Table 95. Lunan Pharmaceutical Group Corporation Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Lunan Pharmaceutical Group Corporation Main Business
Table 97. Lunan Pharmaceutical Group Corporation Latest Developments
Table 98. Hansoh Pharmaceutical Group Company Limited Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Hansoh Pharmaceutical Group Company Limited Fulvestrant Injection Product Portfolios and Specifications
Table 100. Hansoh Pharmaceutical Group Company Limited Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Hansoh Pharmaceutical Group Company Limited Main Business
Table 102. Hansoh Pharmaceutical Group Company Limited Latest Developments
Table 103. Qilu Pharmaceutical Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Qilu Pharmaceutical Fulvestrant Injection Product Portfolios and Specifications
Table 105. Qilu Pharmaceutical Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Qilu Pharmaceutical Main Business
Table 107. Qilu Pharmaceutical Latest Developments
Table 108. Vetter Pharma-Fertigung GmbH & Co. KG Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Vetter Pharma-Fertigung GmbH & Co. KG Fulvestrant Injection Product Portfolios and Specifications
Table 110. Vetter Pharma-Fertigung GmbH & Co. KG Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Vetter Pharma-Fertigung GmbH & Co. KG Main Business
Table 112. Vetter Pharma-Fertigung GmbH & Co. KG Latest Developments
Table 113. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Fulvestrant Injection Product Portfolios and Specifications
Table 115. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Main Business
Table 117. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Latest Developments
Table 118. Sandoz Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Sandoz Fulvestrant Injection Product Portfolios and Specifications
Table 120. Sandoz Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Sandoz Main Business
Table 122. Sandoz Latest Developments
Table 123. Hikma Pharmaceuticals Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Hikma Pharmaceuticals Fulvestrant Injection Product Portfolios and Specifications
Table 125. Hikma Pharmaceuticals Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Hikma Pharmaceuticals Main Business
Table 127. Hikma Pharmaceuticals Latest Developments
Table 128. Teva Pharmaceuticals Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Teva Pharmaceuticals Fulvestrant Injection Product Portfolios and Specifications
Table 130. Teva Pharmaceuticals Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Teva Pharmaceuticals Main Business
Table 132. Teva Pharmaceuticals Latest Developments
Table 133. Eugia US Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Eugia US Fulvestrant Injection Product Portfolios and Specifications
Table 135. Eugia US Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Eugia US Main Business
Table 137. Eugia US Latest Developments
Table 138. Xiromed LLC Basic Information, Fulvestrant Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Xiromed LLC Fulvestrant Injection Product Portfolios and Specifications
Table 140. Xiromed LLC Fulvestrant Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Xiromed LLC Main Business
Table 142. Xiromed LLC Latest Developments
List of Figures
Figure 1. Picture of Fulvestrant Injection
Figure 2. Fulvestrant Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fulvestrant Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Fulvestrant Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Fulvestrant Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Original Drugs
Figure 10. Product Picture of Generic Drugs
Figure 11. Global Fulvestrant Injection Sales Market Share by Type in 2022
Figure 12. Global Fulvestrant Injection Revenue Market Share by Type (2018-2023)
Figure 13. Fulvestrant Injection Consumed in Hospital
Figure 14. Global Fulvestrant Injection Market: Hospital (2018-2023) & (K Units)
Figure 15. Fulvestrant Injection Consumed in Clinic
Figure 16. Global Fulvestrant Injection Market: Clinic (2018-2023) & (K Units)
Figure 17. Fulvestrant Injection Consumed in Other
Figure 18. Global Fulvestrant Injection Market: Other (2018-2023) & (K Units)
Figure 19. Global Fulvestrant Injection Sales Market Share by Application (2022)
Figure 20. Global Fulvestrant Injection Revenue Market Share by Application in 2022
Figure 21. Fulvestrant Injection Sales Market by Company in 2022 (K Units)
Figure 22. Global Fulvestrant Injection Sales Market Share by Company in 2022
Figure 23. Fulvestrant Injection Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Fulvestrant Injection Revenue Market Share by Company in 2022
Figure 25. Global Fulvestrant Injection Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Fulvestrant Injection Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Fulvestrant Injection Sales 2018-2023 (K Units)
Figure 28. Americas Fulvestrant Injection Revenue 2018-2023 ($ Millions)
Figure 29. APAC Fulvestrant Injection Sales 2018-2023 (K Units)
Figure 30. APAC Fulvestrant Injection Revenue 2018-2023 ($ Millions)
Figure 31. Europe Fulvestrant Injection Sales 2018-2023 (K Units)
Figure 32. Europe Fulvestrant Injection Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Fulvestrant Injection Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Fulvestrant Injection Revenue 2018-2023 ($ Millions)
Figure 35. Americas Fulvestrant Injection Sales Market Share by Country in 2022
Figure 36. Americas Fulvestrant Injection Revenue Market Share by Country in 2022
Figure 37. Americas Fulvestrant Injection Sales Market Share by Type (2018-2023)
Figure 38. Americas Fulvestrant Injection Sales Market Share by Application (2018-2023)
Figure 39. United States Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Fulvestrant Injection Sales Market Share by Region in 2022
Figure 44. APAC Fulvestrant Injection Revenue Market Share by Regions in 2022
Figure 45. APAC Fulvestrant Injection Sales Market Share by Type (2018-2023)
Figure 46. APAC Fulvestrant Injection Sales Market Share by Application (2018-2023)
Figure 47. China Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Fulvestrant Injection Sales Market Share by Country in 2022
Figure 55. Europe Fulvestrant Injection Revenue Market Share by Country in 2022
Figure 56. Europe Fulvestrant Injection Sales Market Share by Type (2018-2023)
Figure 57. Europe Fulvestrant Injection Sales Market Share by Application (2018-2023)
Figure 58. Germany Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Fulvestrant Injection Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Fulvestrant Injection Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Fulvestrant Injection Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Fulvestrant Injection Sales Market Share by Application (2018-2023)
Figure 67. Egypt Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Fulvestrant Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Fulvestrant Injection in 2022
Figure 73. Manufacturing Process Analysis of Fulvestrant Injection
Figure 74. Industry Chain Structure of Fulvestrant Injection
Figure 75. Channels of Distribution
Figure 76. Global Fulvestrant Injection Sales Market Forecast by Region (2024-2029)
Figure 77. Global Fulvestrant Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Fulvestrant Injection Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Fulvestrant Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Fulvestrant Injection Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Fulvestrant Injection Revenue Market Share Forecast by Application (2024-2029)

※参考情報 フルベストラント注射は、主に雌性ホルモンであるエストロゲンの受容体に作用することで、特定のタイプの乳がんを治療する目的で使用される薬剤です。フルベストラントは選択的エストロゲン受容体調節薬（SERD）に分類され、特にホルモン依存性の乳がんにおいて重要な役割を果たしています。 フルベストラントは、エストロゲン受容体を遮断するだけでなく、その受容体を降下させる機能を持ちます。この特性により、エストロゲンに依存して増殖する乳がん細胞の増殖を抑え、最終的には腫瘍の成長を阻止します。フルベストラントは、ホルモン療法に抵抗性を示す進行乳がんにも効果が期待されるため、治療の選択肢として重要です。 フルベストラント注射の特徴としては、その投与方法が挙げられます。通常は筋肉内注射として投与され、患者は通常1ヶ月に1回の頻度で治療を受けることが推奨されています。この投与方法により、一定の薬物濃度を血中に保ちながら、持続的な効果を得ることができます。この治療は、内分泌療法の一環として、他の治療法と併用されることも多くあります。 フルベストラントは、主にエストロゲン受容体陽性（ER+）の乳がん患者に使用されます。特に、閉経後の女性においてホルモン療法に抵抗性を示した場合や、初期治療において効果がなかった場合に考慮されることが多いです。研究によって、フルベストラントが他の治療法と組み合わせて使用される場合、治療効果が高まることが示されています。 フルベストラントの関連技術としては、がんの診断や治療計画において、分子標的療法や免疫療法に関する進展が挙げられます。また、遺伝子検査を通じて、乳がんのサブタイプを判別し、最適な治療法を選択することが可能になっています。これにより、患者一人ひとりに合った個別化医療が進展しているのです。 フルベストラントには副作用も存在し、一般的な副作用には倦怠感、悪心、下痢、骨密度の低下、注射部位の反応などがあります。これらの副作用は、患者によって異なるため、治療の際には医師との綿密なコミュニケーションが必要です。患者は自分の体調の変化や副作用についてしっかりと報告することが求められます。 また、フルベストラント治療中は、定期的な血液検査や画像検査が重要です。治療効果の評価や、腫瘍の進行状態を把握するために、治療計画が適宜見直されることもあります。これにより、最良の治療効果を得ることが可能となります。 フルベストラントは、雌性ホルモン受容体に依存した乳がんの治療において、重要な役割を果たす薬剤であり、治療の選択肢を広げる存在であります。その効果的な使用には、患者の状態に応じた適切な管理と、医療チームとの連携が不可欠です。今後の研究によって、さらなる治療の進展が期待されており、より多くの患者に対して効果的な治療が提供されることが望まれます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer